Clover Says It Has No Connection With Supplier Responsible for Arachidonic Acid Oil Contamination Identified in Infant Milk Formula

MT Newswires Live
Feb 05

Clover (ASX:CLV) said that the recent recall actions in the infant formula market relate exclusively to contamination detected in a batch of arachidonic acid oil supplied by an unrelated third-party manufacturer and that it does not source, supply, or have any commercial or technical association with the supplier involved, according to a Thursday Australian bourse filing.

It added that all of its products are safe, fully compliant with all applicable regulations, and are unaffected by the issues currently impacting certain infant formula manufacturers, after undertaking routine controls, supported by targeted additional testing.

The firm said it was assisting customers in evaluating alternative formulation pathways, as well as providing expert guidance on supply continuity planning.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10